Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 1,175 | 2,095 | 1,080 | 1,000 | 0 |
| Gross Profit | 1,175 | 2,095 | 1,080 | 1,000 | N/A |
| Operating Expenses | 10,402 | 10,463 | 7,659 | 20,439 | 0 |
| Operating Income | -9,227 | -8,368 | -6,579 | -19,439 | N/A |
| Interest Expense | 0 | 158 | 187 | 129 | 0 |
| Other Income | 1,641 | 1,637 | -1,239 | -150 | 0 |
| Pre-tax Income | -7,586 | -6,889 | -8,005 | -19,718 | 0 |
| Income Tax | 57 | 44 | 32 | 24 | N/A |
| Net Income Continuous | -7,643 | -6,933 | -8,037 | -19,742 | N/A |
| Net Income | $-7,643 | $-6,933 | $-8,037 | $-19,742 | $N/A |
| EPS Basic Total Ops | 10.58 | -0.27 | -0.31 | -12.14 | N/A |
| EPS Basic Continuous Ops | 10.57 | -0.27 | -0.31 | -12.13 | N/A |
| EPS Diluted Total Ops | 10.58 | -0.27 | -0.31 | -12.14 | N/A |
| EPS Diluted Continuous Ops | 10.57 | -0.27 | -0.31 | -12.13 | N/A |
| EBITDA(a) | $-8,821 | $-8,033 | $-6,445 | $-19,310 | $N/A |